There is a major role for telehealth in oncology care, not only for its convenience but also for giving clinicians the ability to scale nononcologic visits, explained Emeline Aviki, MD, MBA, FACOG, assistant attending gynecologic cancer surgeon at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City and lead of the MSKCC Affordability Working Group.
In an interview at our September Institute for Value-Based Medicine® event in New York City, Emeline Aviki, MD, MBA, FACOG, assistant attending gynecologic cancer surgeon at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City and lead of the MSKCC Affordability Working Group, discussed how benefits of telehealth in oncologic care extend to other specialty care for patients.
Transcript
What role does telehealth play in oncology care?
Telehealth has a major role in cancer care. I think the COVID-19 pandemic showed us how valuable telehealth can be, not only for patient convenience, but also to make sure that patients are compliant with follow-up. Telehealth can offer a lot of convenience for patients.
If you have a follow-up visit with a patient where they don't need a physical exam and they can get their labs at a time that's convenient for them, that's the perfect opportunity to not force them to have to pay for parking [and] take a day off work. Just take a break during work, do your visit with your oncologist, and get back to life.
In addition to offering patients convenient oncology visits, it also offers the ability to scale nononcologic visits that are very helpful for patients; for example, psychiatric care, supportive care for pain management. It would allow you to get those services that are really in shortage to patients no matter where they are.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
No Major Shifts in OBGYN Practice Locations Found Post Dobbs Decision
April 21st 2025Despite widespread concern following the Dobbs v Jackson Women’s Health Organization decision, researchers found no significant changes nationwide in obstetrician and gynecologist (OBGYN) practice locations.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More